Miles Frazier

23-Year-Old GuardOG
PUP-R
Injury Undisclosed
Est. Return 10/5/2025
2025 Fantasy Outlook
There was no outlook written for Miles Frazier in 2025. Check out the latest news below for more on his current fantasy value.
Signed a four-year contract with the Lions in May of 2025.
Starting season on PUP
OGDetroit Lions
Undisclosed
August 27, 2025
The Lions placed Frazier (undisclosed) on the reserve/PUP list Tuesday.
ANALYSIS
The rookie fifth-round pick did not participate in training camp practice due to an undisclosed injury. The nature and severity of Frazier's injury isn't clear, but by starting the regular season on the PUP list, he'll be forced to miss at least four games, making Week 5 against the Bengals on Sunday, Oct. 5 the earliest he can make his NFL regular-season debut.
Read More News
NFL Stats
Loading NFL Stats...
Snap Distribution / Depth Chart
Snap Counts
Snap %
Detroit LionsLions 2024 OG Snap Distribution
#% of Team Snaps

111994%
102186%
14312%
14012%
333%
Loading Weekly Snap Counts...
Measurables Review View College Player Page
How do Miles Frazier's measurables compare to other guard?
This section compares his draft workout metrics with players at the same position. The bar represents the player's percentile rank. For example, if the bar is halfway across, then the player falls into the 50th percentile for that metric and it would be considered average.
Height
6' 6"
 
Weight
317 lbs
 
40-Yard Dash
5.34 sec
 
Vertical Jump
31.0 in
 
Broad Jump
108 in
 
Bench Press
27 reps
 
Hand Length
9.00 in
 
Arm Length
32.75 in
 
Recent RotoWire Articles Featuring Miles Frazier See More
Recent RotoWire Articles Featuring Miles Frazier See More
More Fantasy News
Lands on active/PUP list
OGDetroit Lions
Undisclosed
July 17, 2025
Frazier (undisclosed) was put on the active/PUP list by the Lions on Thursday.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Joining pride in Detroit
OGDetroit Lions
April 26, 2025
The Lions selected Frazier in the fifth round of the 2025 NFL Draft, 171st overall.
ANALYSIS
Subscribe now to instantly reveal our take on this news.